Alteri Wealth LLC acquired a new stake in shares of Danaher Co. (NYSE:DHR – Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm acquired 929 shares of the conglomerate’s stock, valued at approximately $213,000.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Kentucky Retirement Systems Insurance Trust Fund raised its holdings in shares of Danaher by 11.6% during the 4th quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 21,233 shares of the conglomerate’s stock worth $4,874,000 after acquiring an additional 2,202 shares in the last quarter. FAS Wealth Partners Inc. raised its stake in Danaher by 20.6% during the fourth quarter. FAS Wealth Partners Inc. now owns 9,597 shares of the conglomerate’s stock valued at $2,203,000 after purchasing an additional 1,639 shares in the last quarter. ORG Partners LLC lifted its position in Danaher by 1,212.8% during the fourth quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate’s stock valued at $636,000 after purchasing an additional 2,559 shares during the last quarter. Generate Investment Management Ltd purchased a new position in shares of Danaher in the 4th quarter worth $8,044,000. Finally, Compass Capital Management Inc. raised its position in shares of Danaher by 4.8% during the 4th quarter. Compass Capital Management Inc. now owns 237,922 shares of the conglomerate’s stock valued at $54,615,000 after buying an additional 10,994 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.
Analyst Upgrades and Downgrades
Several brokerages have weighed in on DHR. Citigroup reissued a “buy” rating on shares of Danaher in a research note on Monday, April 7th. Raymond James restated a “market perform” rating on shares of Danaher in a report on Monday, February 3rd. Barclays lifted their price objective on shares of Danaher from $205.00 to $215.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 22nd. Wells Fargo & Company lowered their target price on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating for the company in a report on Thursday, January 30th. Finally, The Goldman Sachs Group cut their price target on shares of Danaher from $260.00 to $240.00 and set a “neutral” rating on the stock in a report on Wednesday, April 23rd. Five analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. According to data from MarketBeat, Danaher presently has an average rating of “Moderate Buy” and a consensus price target of $264.40.
Insider Transactions at Danaher
In related news, EVP Christopher Paul Riley sold 15,805 shares of the company’s stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total value of $3,129,390.00. Following the completion of the transaction, the executive vice president now directly owns 15,179 shares of the company’s stock, valued at $3,005,442. This represents a 51.01 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 11.10% of the company’s stock.
Danaher Trading Up 1.2 %
Shares of DHR stock opened at $199.15 on Monday. Danaher Co. has a 1-year low of $171.00 and a 1-year high of $281.70. The firm has a market cap of $142.53 billion, a PE ratio of 37.72, a price-to-earnings-growth ratio of 2.66 and a beta of 0.80. The company has a 50-day moving average of $199.78 and a two-hundred day moving average of $221.43. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05.
Danaher (NYSE:DHR – Get Free Report) last posted its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.62 by $0.26. The firm had revenue of $5.74 billion for the quarter, compared to the consensus estimate of $5.58 billion. Danaher had a return on equity of 10.82% and a net margin of 16.33%. On average, analysts predict that Danaher Co. will post 7.63 EPS for the current year.
Danaher Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, April 25th. Shareholders of record on Friday, March 28th were given a $0.32 dividend. The ex-dividend date was Friday, March 28th. This represents a $1.28 dividend on an annualized basis and a yield of 0.64%. This is a positive change from Danaher’s previous quarterly dividend of $0.27. Danaher’s dividend payout ratio (DPR) is currently 24.85%.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Read More
- Five stocks we like better than Danaher
- What Are the U.K. Market Holidays? How to Invest and Trade
- Western Digital: Is the Storage Sector Set for a Rebound?
- 10 Best Airline Stocks to Buy
- Wingstop Stock Jumps on Q1 Beat, Expansion Outlook
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Why Energy Stocks Like Exxon and Hess Are Back in Focus
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.